Quadria Capital

Quadria Capital, a Singapore-based premier healthcare-focused private equity firm, announced Monday the final close of its Fund III with $1.07 billion in total commitments, significantly exceeding its original $800 million target.

Earlier reports showed Internet entrepreneur Patrick Grove, Singapore-based PE firm Novo Tellus Capital Partners, French alternative investment manager Tikehau Capital SCA are also targeting SPAC-listing on the Singapore exchange. Other interested parties include Turmeric Capital and Temasek’s Vertex Holdings Ltd.